TITLE

New immune enhancing enteral feed for the critically ill

PUB. DATE
June 2000
SOURCE
Perfusion;Jun2000, Vol. 15 Issue 3, p273
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports that Fresenius Kabi has announced the release of a high glutamine tube feed, Fresenius Reconovan. Purpose in the formulation of the product; Benefits of the product; Amount in which the product is sold.
ACCESSION #
3533775

 

Related Articles

  • ADDING and REPLACING Fresenius Kabi Announces Launch of Oxaliplatin Injection, USP.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article evaluates the injecting system "Oxaliplatin Injection," by Fresenius Kabi Ltd.

  • Fresenius Kabi reports it will acquire Fenwal.  // Medical Device Daily;7/23/2012, Vol. 16 Issue 141, p2 

    The article reports on a definitive agreement signed by infusion therapy provider Fresenius Kabi to acquire Fenwal, a company that specializes in separation technologies for blood and cell collection and therapy.

  • PRODUCT NEWS.  // British Journal of Community Nursing;Feb2002, Vol. 7 Issue 2, p109 

    Presents several medical products in the U.S. Improvement on Thick & Easy Instant Food Thickener from Fresenius Kabi; Price of Lipitor from Pfizer; Efficacy of Risperdal in reducing relapse risk among patients with schizophrenia or schizoaffective disorder.

  • Maintaining Manufacturing.  // Pharmaceutical Technology;May2009, Vol. 33 Issue 5, p86 

    The article focuses on the business maintenance growth of Fresenius Kabi Ltd. in South Africa. It mentions that the said company remained its stability in manufacturing their intravenous solutions, despite the slumping of other pharmaceutical companies in the country. Wilma Stapelberg, Market...

  • Octapharma and Fresenius Kabi Enter Agreement for a HESylated Recombinant Protein.  // BioPharm International;Dec2009, Vol. 22 Issue 12, p18 

    The article reports on the license agreement of Octapharma Group and Fresenius Kabi Ltd. for the use of HESylation technology in the U.S. The technology will develop a HESylated recombinant protein to allow modification of drugs and characteristics to HES molecules. It notes that the company...

  • Fresenius Kabi Increases Stake in Dabur Pharma. Ramesh, Deepti // Chemical Week;8/25/2008, Vol. 170 Issue 26, p29 

    The article reports on Fresenius Kabi's acquisition of Indian generics and active pharmaceutical ingredients (API) firm Dabur Pharma by purchasing a further 17.6% stake in the firm. A 73.3% stake in Dabur Pharma was purchased by the Fresenius SE unit in April 2008 for approximately €139...

  • Gelcap-assisted fiberoptic nasogastric feeding tube placement. Deschler, Daniel G.; Lustig, Lawrence // ENT: Ear, Nose & Throat Journal;Feb1996, Vol. 75 Issue 2, p102 

    Describes the gelcap-assisted fiberoptic nasogastric feeding tube placement for head and neck surgery patients. Use of gelcap to join the flexible feeding tube into a safe stent; Advantages of technique over other alternatives.

  • Gastrostomy and jejunostomy tubes. Eisenberg, Patti G.; O'Connor, Eileen // RN;Nov94, Vol. 57 Issue 11, p54 

    Focuses on the nursing care involved when the enteral feeding tube is surgically implanted. Tube insertion procedures; Complications involving gastrotomy and jejunostomy tubes; Evaluation of patient's psychological state. INSET: When a gastrostomy is a jejunostomy..

  • Which product is best for securing an NG tube?  // RN;Nov95, Vol. 58 Issue 11, p16 

    Presents an overview of a study on the best method of securing nasogastric (NG) tubes conducted by Susan M. Burns et al., published in the `American Journal of Critical Care.' Equipment used in securing NG tubes; Preparation before securing.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics